SOURCE: S3 Investment Company

December 28, 2006 10:06 ET

S3 Investment Company Announces Strong December 2006 Sales for SINO UJE's Ulrich Product Line

Orders for Ulrich Injector Systems and Associated Disposals Topped $200,000 for the Month

TEMECULA, CA -- (MARKET WIRE) -- December 28, 2006 -- S3 Investment Company, Inc. (PINKSHEETS: SEIH), a holding company with two subsidiaries doing business in the China market, today announced strong sales in the month of December for its SINO UJE subsidiary, particularly through orders for Ulrich GmbH & Co. injector systems, during the month of December 2006.

The Ulrich (www.ulrich-ulm.de/eng/start.html) is a world leader in the design and manufacture of injector systems used for medical imaging applications, such as CT and MRI equipment.

SINO UJE has been granted exclusive distribution rights in China to high-tech medical and industrial products manufactured by leading companies in Europe, North America and Japan. These products are marketed to end-users, including major Chinese hospitals and private companies in a variety of fields, as well as to major original equipment manufacturers (OEMs). In the case of Ulrich products, CT or MRI original equipment manufacturers, such as GE and Siemens, package the products with their technologies for sale into worldwide markets.

"Just as our SINO UJE subsidiary began the year with a brisk pace of orders for Ulrich products, it has closed the year with a large volume of Ulrich orders in December," stated S3 chief executive officer Jim Bickel.

"Orders for Ulrich injector systems and the disposable products associated with its equipment topped $200,000 for the month. While this is just one of SINO UJE's product lines, it has been the most active in December, and as we work to increase the financial resources that SINO UJE has at its disposal, we expect its capacity to fill a greater number of Ulrich orders to increase, expanding the overall revenue potential of SINO UJE.

"At the same time, we will assist SINO UJE in its efforts to sign additional exclusive distributor agreements for the China market with major western equipment manufacturers, so that the financial performance of this subsidiary can continue to improve in each upcoming fiscal quarter," added Mr. Bickel.

To sign up to receive information by email directly from S3 Investment Company when new press releases, investor newsletters, SEC filings or other information is disclosed, please visit http://www.s3investments.com/ealert.php.

About S3 Investment Company

S3 Investment Company, Inc. (http://www.s3investments.com) is a holding company with two subsidiaries doing business in the China market. S3 holds a 100% equity interest in Redwood Capital (http://www.redwoodcapinc.com), which assists private Chinese companies in accessing U.S. capital markets by utilizing a network of investment banking relationships, and a 51% equity interest in SINO UJE (http://www.sinouje.com), a non-stocking distributor of medical and industrial high-tech products to markets throughout China. SINO UJE has been granted exclusive distribution rights in China to medical and industrial products manufactured by leading companies in Europe, North America and Japan. These products are marketed to end-users, including major Chinese hospitals and private companies in a variety of fields, as well as original equipment manufacturers (OEMs), such as Phillips, Siemens and GE, that package the products with their technologies.

Any statements contained herein related to future events are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements. S3 Investment Company, Inc. undertakes no obligation to update any such statements to reflect actual events.

Contact Information

  • Contact:
    Gemini Financial Communications
    A. Beyer
    (951) 587-8072
    Email Contact